Showing results (1481-1490 of 4,366) with videos related to

Sort By:
Pageof 437
Clinical Immunology (Orlando, Fla.)|May 3, 2017
Granzyme B producing B-cells in renal transplant patientsJiqiao Zhu, Ye Zeng, Sebastian Dolff, et al.
Clinical Immunology (Orlando, Fla.)|August 23, 2016
Compstatin Cp40 blocks hematin-mediated deposition of C3b fragments on erythrocytes: Implications for treatment of malarial anemiaMargaret A Lindorfer, Erika M Cook, Edimara S Reis, et al.
Clinical Immunology (Orlando, Fla.)|December 1, 2005
Glucocorticosteroid therapy decreases CD14-expression and CD14-mediated LPS-binding and activation of monocytes in patients suffering from systemic lupus erythematosusAndrea Sümegi, Péter Antal-Szalmás, Magdolna Aleksza, et al.
Clinical Immunology (Orlando, Fla.)|December 7, 2005
Dexamethasone preferentially suppresses plasmacytoid dendritic cell differentiation and enhances their apoptotic deathMasanori Abe, Angus W Thomson
Clinical Immunology (Orlando, Fla.)|December 8, 2005
Selection of a human anti-RhD monoclonal antibody for therapeutic use: impact of IgG glycosylation on activating and inhibitory Fc gamma R functionsSophie Sibéril, Christophe de Romeuf, Nicolas Bihoreau, et al.
Clinical Immunology (Orlando, Fla.)|March 19, 2010
Primary immunodeficiencies of protective immunity to primary infectionsAziz Bousfiha, Capucine Picard, Stéphanie Boisson-Dupuis, et al.
Clinical Immunology (Orlando, Fla.)|March 16, 2010
d-Dimer and CRP levels are elevated prior to antiretroviral treatment in patients who develop IRISBrian O Porter, G Laissa Ouedraogo, Jessica N Hodge, et al.
Clinical Immunology (Orlando, Fla.)|January 23, 2010
Expression of the HLA-C2-specific activating killer-cell Ig-like receptor KIR2DS1 on NK and T cellsCéline Cognet, Catherine Farnarier, Laurent Gauthier, et al.
Clinical Immunology (Orlando, Fla.)|June 22, 2018
A potentially important role for T cells and regulatory T cells in Langerhans cell histiocytosisJenée M Mitchell, Stuart P Berzins, George Kannourakis
Clinical Immunology (Orlando, Fla.)|July 4, 2018
Hematological Malignancies Associated With Primary Immunodeficiency DisordersLucy Duan, Eyal Grunebaum
Pageof 437